Prof Katherine Payne PhD, MSc, DipClinPharm, BPharm, FRPharmS

Professor of Health Economics

Full contact details
View graph of relations

Research interests

Professor Katherine Payne is an academic health economist with 26-years applied and methodological research experience in the economic evaluation (using RCT and decision-analytic models) and valuation (using discrete choice experiments and contingent valuation) of health care interventions and specifically precision medicine. She developed an interest in genomics when working as the health economist for the North West Genetics Knowledge Park (2003 to 2007) and continues to collaborate closely with colleagues based in the Manchester Centre for Genomic Medicine. This research profile has supported her methodological interest of how to identify, measure and value the benefits of interventions that extend beyond the impact on health.

She has over 140 peer-reviewed publications and had a key role in multi-disciplinary research programmes and projects that, in the last three years, generated a total of over £15.5m for The University of Manchester from MRC, NIHR, Department of Health and Charities (Versus Arthritis and Cancer Research UK). She has been the lead economist on a number of large MRC-funded consortia looking at using targeted approaches (developing prescribing algorithms) for biologics and other medicines (for lupus, psoriasis, rheumatoid arthritis). She is also one of the three Manchester co-applicants on the successful Research Design Service (tender 3) proposal and line manages frontline advisors.

She has a particular interest in the use of economic evidence to inform decision-making in practice and was a member of a NICE Technology Appraisal Committee between October 2003 and 2012. She was a member of a NIHR PGFAR review panel (to March 2021) and has been a member of numerous national funding review panels appraising  projects on the economics of precision medicine (Canada, UK, The Netherlands, France, Switzerland, Singapore, Luxembourg).

Methodological knowledge

Model-based and prospective economic evaluations

Stated preference methods including discrete choice experiments and contingent valuation

Valuing health and non-health outcomes


Research and projects